SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : HuMAB companies -- Ignore unavailable to you. Want to Upgrade?

To: JOEBT1 who wrote (45)9/6/2000 2:27:09 PM
From: scaram(o)uche  Respond to of 1022
 
Duly noted. My criticism, in the past, has been that Mitch was slow, IMO, to recognize and/or distribute bad news.

Normally I ditch a management team like that, forever. I have noted, however, that they have been releasing news in a more responsible fashion. I sincerely hope that DM1 conjugates are not immunogenic or that immunogenicity can be negotiated successfully.

Again.... nice call.



To: JOEBT1 who wrote (45)9/6/2000 4:26:49 PM
From: nigel bates  Respond to of 1022
 
I must confess to a small speculative holding in IMGN, fairly recently acquired. The jury may still be out on this one, but the recent deals certainly provide some weighty evidence in favour.

nig


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News